Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1952 1
1953 3
1957 1
1958 1
1959 1
1961 1
1962 1
1963 3
1965 2
1966 2
1968 2
1969 1
1970 5
1971 3
1972 4
1973 1
1974 4
1975 3
1976 11
1977 7
1978 3
1979 4
1980 5
1981 12
1982 16
1983 13
1984 11
1985 23
1986 17
1987 28
1988 25
1989 20
1990 22
1991 26
1992 18
1993 17
1994 21
1995 20
1996 21
1997 22
1998 18
1999 11
2000 7
2001 12
2002 9
2003 9
2004 9
2005 10
2006 9
2007 12
2008 9
2009 3
2010 9
2011 14
2012 12
2013 8
2014 10
2015 9
2016 12
2017 12
2018 9
2019 9
2020 20
2021 13
Text availability
Article attribute
Article type
Publication date

Search Results

630 results
Results by year
Filters applied: . Clear all
Page 1
A de novo compound targeting Ī±-synuclein improves deficits in models of Parkinson's disease.
Wrasidlo W, Tsigelny IF, Price DL, Dutta G, Rockenstein E, Schwarz TC, Ledolter K, Bonhaus D, Paulino A, Eleuteri S, Skjevik ƅA, Kouznetsova VL, Spencer B, Desplats P, Gonzalez-Ruelas T, Trejo-Morales M, Overk CR, Winter S, Zhu C, Chesselet MF, Meier D, Moessler H, Konrat R, Masliah E. Wrasidlo W, et al. Among authors: price dl. Brain. 2016 Dec;139(Pt 12):3217-3236. doi: 10.1093/brain/aww238. Epub 2016 Sep 27. Brain. 2016. PMID: 27679481 Free PMC article.
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma.
Ma DJ, Price KA, Moore EJ, Patel SH, Hinni ML, Garcia JJ, Graner DE, Foster NR, Ginos B, Neben-Wittich M, Garces YI, Chintakuntlawar AV, Price DL, Olsen KD, Van Abel KM, Kasperbauer JL, Janus JR, Waddle M, Miller R, Shiraishi S, Foote RL. Ma DJ, et al. Among authors: price dl. J Clin Oncol. 2019 Aug 1;37(22):1909-1918. doi: 10.1200/JCO.19.00463. Epub 2019 Jun 4. J Clin Oncol. 2019. PMID: 31163012 Free PMC article. Clinical Trial.
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.
Chintakuntlawar AV, Yin J, Foote RL, Kasperbauer JL, Rivera M, Asmus E, Garces NI, Janus JR, Liu M, Ma DJ, Moore EJ, Morris JC 3rd, Neben-Wittich M, Price DL, Price KA, Ryder M, Van Abel KM, Hilger C, Samb E, Bible KC. Chintakuntlawar AV, et al. Among authors: price dl. Thyroid. 2019 Nov;29(11):1615-1622. doi: 10.1089/thy.2019.0086. Thyroid. 2019. PMID: 31595822 Clinical Trial.
Reply to A.S. Garden.
Ma DJ, Price KA, Moore EJ, Patel SH, Hinni ML, Garcia JJ, Graner DE, Neben-Wittich M, Garces YI, Chintakuntlawar AV, Price DL, Van Abel KM, Kasperbauer JL, Janus JR, Waddle M, Miller RC, Shiraishi S, Mutter RW, Corbin KS, Park SS, Foote RL. Ma DJ, et al. Among authors: price dl. J Clin Oncol. 2019 Dec 20;37(36):3559-3560. doi: 10.1200/JCO.19.02144. Epub 2019 Sep 26. J Clin Oncol. 2019. PMID: 31557088 No abstract available.
Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL. Lee MK, et al. Among authors: price dl. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8968-73. doi: 10.1073/pnas.132197599. Proc Natl Acad Sci U S A. 2002. PMID: 12084935 Free PMC article.
Oncocytoma Presenting as a Fat-Containing Intraparotid Mass.
Anzalone CL, Nagelschneider AA, Sims JR, GarcĆ­a JJ, DeLone DR, Price DL. Anzalone CL, et al. Among authors: price dl. Ear Nose Throat J. 2019 Aug;98(7):403-404. doi: 10.1177/0145561319841210. Epub 2019 Apr 8. Ear Nose Throat J. 2019. PMID: 30961383 Free article. No abstract available.
630 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page